Oak Street Health, Inc. OSH
We take great care to ensure that the data presented and summarized in this overview for Oak Street Health, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OSH
View all-
Eaton Vance Management Boston, MA898KShares$00.03% of portfolio
-
Lloyd Park, LLC Wilmette, IL32KShares$00.97% of portfolio
-
Zeke Capital Advisors, LLC Berwyn, PA16.9KShares$00.02% of portfolio
-
Burleson & Company, LLC1.8KShares$00.01% of portfolio
-
American Portfolios Advisors Holbrook, NY408Shares$00.0% of portfolio
-
Private Capital Group, LLC175Shares$00.0% of portfolio
-
Trustcore Financial Services, LLC140Shares$00.0% of portfolio
-
Wipfli Financial Advisors Llc,63Shares$00.0% of portfolio
Latest Institutional Activity in OSH
Top Purchases
Top Sells
About OSH
Oak Street Health, Inc., together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas. The company was founded in 2012 and is headquartered in Chicago, Illinois.
Insider Transactions at OSH
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 02
2023
|
Newlight Partners LP Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
32,550,265
-100.0%
|
$1,269,460,335
$39.0 P/Share
|
May 02
2023
|
Timothy M Cook Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
84,482
-100.0%
|
$3,294,798
$39.0 P/Share
|
May 02
2023
|
Timothy M Cook Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
1,456,206
-100.0%
|
$56,792,034
$39.0 P/Share
|
May 02
2023
|
Robert Guenthner Chief Legal Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
489,270
-100.0%
|
$19,081,530
$39.0 P/Share
|
May 02
2023
|
Regina M. Benjamin Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
23,881
-100.0%
|
$931,359
$39.0 P/Share
|
May 02
2023
|
Mohit Kaushal Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
215,224
-100.0%
|
$8,393,736
$39.0 P/Share
|
May 02
2023
|
Paul B. K. Kusserow Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
480,013
-100.0%
|
$18,720,507
$39.0 P/Share
|
May 02
2023
|
Michael T Pykosz Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,040,273
-100.0%
|
$40,570,647
$39.0 P/Share
|
May 02
2023
|
Michael T Pykosz Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
6,126,706
-100.0%
|
$238,941,534
$39.0 P/Share
|
May 02
2023
|
Kim Keck Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
94,960
-100.0%
|
$3,703,440
$39.0 P/Share
|
May 02
2023
|
Julie D Klapstein Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
31,684
-100.0%
|
$1,235,676
$39.0 P/Share
|
May 02
2023
|
Griffin Myers Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
4,845,659
-100.0%
|
$188,980,701
$39.0 P/Share
|
May 02
2023
|
Griffin Myers Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,511
-100.0%
|
$331,929
$39.0 P/Share
|
May 02
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
1,080,970
-100.0%
|
$42,157,830
$39.0 P/Share
|
May 02
2023
|
Geoffrey M Price Chief Innovation Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,879,525
-100.0%
|
$151,301,475
$39.0 P/Share
|
May 02
2023
|
Brian Clem Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
569,826
-100.0%
|
$22,223,214
$39.0 P/Share
|
May 02
2023
|
Cheryl Dorsey Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
29,484
-100.0%
|
$1,149,876
$39.0 P/Share
|
May 02
2023
|
General Atlantic LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
61,384,475
-100.0%
|
$2,393,994,525
$39.0 P/Share
|
Apr 26
2023
|
Newlight Partners LP Director |
SELL
Bona fide gift
|
Indirect |
80,000
-100.0%
|
-
|
Apr 23
2023
|
Paul B. K. Kusserow Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,140
+1.06%
|
-
|